openPR Logo
Press release

Autoimmune Disease Diagnostics Market Worth $5,054.12 Million by 2026 | Industry Players: Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, and others

04-11-2019 11:40 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

The global autoimmune disease diagnostics market Size is anticipated to reach over USD 5,054.12 Million by 2026, according to a new research published by Polaris Market Research

Request for a sample of this research report @https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/request-for-sample?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika11_April_autoimmune-disease-diagnostics_smpl&utm_content=Content

In general, our body immune system protects the body from foreign particles such as virus and bacteria. Autoimmune diseases arise when the body immune system attacks one or more healthy cells which are operating normally the cause for this may be the irregularities of genes. The malfunctioning of a body immune system is the outcome of the failure to identify organs, tissues, immune cells, and generating autoantibodies targeting these cells.

Autoimmune disease diagnostics market is predominantly driven by key factors such as the increasing occurrence of autoimmune disease. for instance, according to The National Institutes of Health (NIH) 2015, approximately 23.5 million Americans were affected by autoimmune disease. Moreover, increase in automation technologies, patient consciousness regarding rising healthcare concerns, increasing government support, increase in healthcare spending, and easy and rapid performing diagnosis test results and prevention of disease are another factors boosting the market growth. However, huge turnaround time for diagnostic test results, high cost associated with the diagnostics tests, and high frequency of false-positive results are some of the major factors hindering the global autoimmune diagnostics market growth. In addition, lack of awareness concerning the various diseases and diagnostic procedures are another factors affecting the market growth adversely.

The global autoimmune disease diagnostics market is segmented on the basis of type, end user, and geography. On the basis of type, the global autoimmune disease diagnostics market is segmented into systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. The systemic autoimmune disease diagnostics is further categorized into rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and others. On the other side, the localized autoimmune disease diagnostics is further categorized into multiple sclerosis, type 1 diabetes, hashimoto’s thyroiditis, idiopathic thrombocytopenic purpura, and others. In 2017, localized disease diagnostics dominated the overall market. The dominance is majorly attributed to the existence of large process measurements and moderately higher patient awareness level in comparison to systemic diseases. On the basis of end users, the global autoimmune disease diagnostics market is segmented into Hospitals, Diagnostics Centers, and Research Laboratories.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/inquire-before-buying?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika11_April_autoimmune-disease-diagnostics_inq&utm_content=Content

In terms of geography, North America is estimated to dominate the global autoimmune disease diagnostics market. The dominance is majorly attributed to increasing prevalence of some of the common autoimmune diseases such as type1 diabetes and rheumatoid arthritis. The surge in funding by private and government organizations, growing regulatory scenario observed by World Health Organization (WHO), and advancement in technology are some of the other factors driving the growth of the autoimmune disease diagnostics market in North America.

Some major key players in global autoimmune disease diagnostics market includes Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, Inc. and B. Braun Melsungen AG among others.

Autoimmune Disease Diagnostics Market Size and Forecast by Type

Key findings

o Systemic autoimmune disease diagnostics
• Rheumatoid arthritis
• Ankylosing spondylitis
• Systemic lupus erythematosus (SLE)
• Others
 Localized autoimmune disease diagnostics
o Multiple sclerosis
o Type 1 diabetes
o Hashimoto's Thyroiditis
o Idiopathic thrombocytopenic purpura
o Others

Browse for full research summary: https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika11_April_autoimmune-disease-diagnostics_RD&utm_content=Content

Autoimmune Disease Diagnostics Market Size and Forecast by End User

Key findings

o Hospitals
o Diagnostics Centers
o Research Laboratories

Autoimmune Disease Diagnostics Market Size and Forecast by Regions

Key findings

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Italy
o Asia Pacific
 China
 India
 Japan
 Australia
o Latin America
 Brazil
 Mexico
o Middle East & Africa

Check for discount: https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/request-for-discount-pricing?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika11_April_autoimmune-disease-diagnostics_dsc&utm_content=Content

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-

Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market Worth $5,054.12 Million by 2026 | Industry Players: Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, and others here

News-ID: 1699187 • Views:

More Releases from Polaris Market Research & Consulting

U.S. Riflescopes & Red Dot Sight Market Outlook to 2034: Key Trends, Investment Priorities, and Strategic Forecasts
U.S. Riflescopes & Red Dot Sight Market Outlook to 2034: Key Trends, Investment …
Polaris Market Research recently introduced the latest update on U.S. Riflescopes & Red Dot Sight Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Riflescopes & Red Dot Sight market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get
U.S. Blank Apparel Market on Track for USD 5.92 Billion By 2034, Growing at a 5.8 % CAGR
U.S. Blank Apparel Market on Track for USD 5.92 Billion By 2034, Growing at a 5. …
Polaris Market Research recently introduced the latest update on U.S. Blank Apparel Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Blank Apparel market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of the industry
U.S. Small Molecule CDMO Market Forecast 2025-2034: Key Trends, Growth Opportunities, and Revenue Outlook
U.S. Small Molecule CDMO Market Forecast 2025-2034: Key Trends, Growth Opportuni …
Polaris Market Research recently introduced the latest update on U.S. Small Molecule CDMO Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Small Molecule CDMO market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of
U.S. Liquid Embolic Agent Market Forecast to Hit USD 156.91 Million by 2034 with 9.0% CAGR Surge
U.S. Liquid Embolic Agent Market Forecast to Hit USD 156.91 Million by 2034 with …
Polaris Market Research recently introduced the latest update on U.S. Liquid Embolic Agent Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the U.S. Liquid Embolic Agent market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of

All 5 Releases


More Releases for Autoimmune

Autoimmune Polyglandular Syndrome Market analysis reveals CAGR of 6.20 percent t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoimmune Polyglandular Syndrome Type 1 Market - (By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration (Oral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)),
Reshaping Autoimmune Therapy Landscape: Protheragen Announces Small Molecule Dru …
Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune diseases. New York, USA - Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune conditions. From target identification to preclinical studies, Protheragen leverages its expertise in small molecule drug design and development to offer tailored services that provide biotech and pharmaceutical companies
Autoimmune Disease Diagnosis Market - Strength in Knowledge, Defying Autoimmune …
Newark, New Castle, USA: The "Autoimmune Disease Diagnosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Autoimmune Disease Diagnosis Market: https://www.growthplusreports.com/report/autoimmune-disease-diagnosis-market/7616 This latest report researches the industry structure,
Autoimmune Drugs Market: Understanding How They Work and Their Importance in Tre …
Allied Market Research recently said Autoimmune diseases are a group of disorders in which the body's immune system attacks its own healthy tissues, mistaking them for foreign invaders. These diseases can affect any part of the body, including the joints, skin, and organs. They can be debilitating, chronic, and sometimes life-threatening. Autoimmune drugs are medications that help to suppress or modulate the immune system's response to prevent it from attacking
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants are
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include